Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Product sales, net	$ 2,597,598	$ 2,700,902
Cost of products sold	708,135	1,018,476
Gross profit	1,889,463	1,682,426
Selling, general and administrative expenses	3,074,572	3,115,629
Research and development expenses	140,347	464,466
Depreciation and amortization expense	17,220	16,814
Total operating expenses	3,232,139	3,596,909
Loss from operations	(1,342,676)	(1,914,483)
Interest income (expense)	23,345	(4,742)
Loss before provision for income taxes	(1,319,331)	(1,919,225)
Provision for income taxes	0	0
Net loss	(1,319,331)	(1,919,225)
Net loss attributable to noncontrolling interests	(11,665)	(17,502)
Net loss attributable to Milestone Scientific Inc.	$ (1,307,666)	$ (1,901,723)
Net loss per share applicable to common stockholders—
Basic and diluted (in dollars per share)	$ (0.02)	$ (0.03)
Weighted average shares outstanding and to be issued—
Basic and diluted (in shares)	72,104,234	69,013,001